WPD Pharmaceuticals Inc. (WPDPF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -154.79 Thousand | -2.52 Million | -1.17 Million | -1.08 Million | -170.39 Thousand | -588.05 Thousand |
| Net Income | -60.44 Thousand | 2.84 Million | -4.44 Million | -5.9 Million | -11.61 Million | -593.49 Thousand |
| Depreciation & Amortization | 4765.39 | 18.02 Thousand | 229.44 Thousand | 307.51 Thousand | 100.73 Thousand | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 44.17 Thousand | 125.83 Thousand | 3.39 Million | 1.97 Million | - |
| Change in working capital | -12.14 Thousand | -2.23 Million | 2.68 Million | 749.88 Thousand | 148.25 Thousand | 12.62 Thousand |
| Other non-cash items | -86.97 Thousand | -3.07 Million | 813 Thousand | 4.24 Million | 9.79 Million | 39.97 Thousand |
| Investing Cash Flow | - | -176.34 Thousand | -56.11 Thousand | -506.63 Thousand | 2.81 Million | -2.11 Million |
| Investments in PPE | -1.51 | -26.81 Thousand | -56.11 Thousand | -506.63 Thousand | -65.12 Thousand | - |
| Acquisitions | - | -202.7 Thousand | - | - | 2.87 Million | - |
| Investment purchases | - | - | - | - | - | -2.11 Million |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -149.53 Thousand | -53.44 Thousand | -459.27 Thousand | -50.15 Thousand | - |
| Financing Cash Flow | 201.63 Thousand | 904.02 Thousand | 784.45 Thousand | 804.5 Thousand | 380.91 Thousand | 3.16 Million |
| Debt repayment | -201.63 Thousand | -537 Thousand | -790.67 Thousand | -3821.04 | -380.91 Thousand | -11.84 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 371.33 Thousand | - | 858.65 Thousand | - | 3.18 Million |
| Other Financing Activities | - | 503.37 Thousand | 790.88 Thousand | 855.89 Thousand | 342.73 Thousand | - |
| Accounts receivables | -9505.88 | -44.56 Thousand | 4642.40 | 129.93 Thousand | 125 Thousand | -47.15 Thousand |
| Accounts payables | - | -415.35 Thousand | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -2641.57 | -2.19 Million | 2.67 Million | 619.94 Thousand | - | 59.78 Thousand |
| Cash at beginning of period | 17.57 Thousand | 1.35 Million | 1.46 Million | 2.72 Million | 2481.00 | 159.36 Thousand |
| Cash at end of period | 64.8 Thousand | 17.55 Thousand | 1.35 Million | 1.46 Million | 2.95 Million | 2.72 Million |
| Capital Expenditure | -1.51 | -26.81 Thousand | -56.11 Thousand | -506.63 Thousand | -65.12 Thousand | - |
| Effect of forex changes on cash | - | 757.91 Thousand | 319.6 Thousand | -63.44 Thousand | -72.97 Thousand | - |
| Net cash flow / Change in cash | 47.22 Thousand | -1.33 Million | -115.98 Thousand | -1.26 Million | 2.94 Million | 2.57 Million |
| Free Cash Flow | -154.79 Thousand | -2.55 Million | -1.23 Million | -1.59 Million | -235.52 Thousand | -588.05 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -13.88 Thousand | -116.35 Thousand | -60.42 Thousand | 92.34 Thousand | -63.19 Thousand | -59.33 Thousand |
| Depreciation & Amortization | 2705.00 | 2706.00 | 4765.39 | 2.12 | 3509.00 | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 52.51 Thousand | 47.62 Thousand | 18.57 Thousand | -3039.13 | 13.89 Thousand | -5602.93 |
| Other non-cash items | -40.85 Thousand | 16.9 Thousand | -103.39 Thousand | -128.87 Thousand | 12.19 Thousand | 3764.93 |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | - | 201.57 Thousand | - | -24.16 Thousand | 211.23 Thousand |
| Debt repayment | - | - | -201.57 Thousand | -24.78 | -24.16 Thousand | -211.23 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | 24.78 | -24.17 | 422.46 Thousand |
| Accounts receivables | -3459.13 | -3554.43 | -9502.93 | -3887.18 | -2625.67 | -1798.49 |
| Accounts payables | - | - | - | - | 33.44 Thousand | -5043.00 |
| Inventory | - | - | - | - | -33.44 Thousand | 5043.00 |
| Other working capital | 55.97 Thousand | 51.17 Thousand | 28.07 Thousand | 848.06 | 16.52 Thousand | -3804.44 |
| Cash at beginning of period | 8002.09 | 64.78 Thousand | 17.55 Thousand | 105.59 Thousand | 167.42 Thousand | 17.01 Thousand |
| Cash at end of period | 2231.56 | 8002.09 | 64.78 Thousand | 64.78 Thousand | 105.59 Thousand | 167.42 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -5770.53 | -56.77 Thousand | 47.23 Thousand | -40.81 Thousand | -61.82 Thousand | 150.4 Thousand |
| Free Cash Flow | -5689.23 | -55.38 Thousand | -154.74 Thousand | -43.45 Thousand | -33.59 Thousand | -61.17 Thousand |
JAGX
0332
1165
TENX
IIPR
6183